Where we stand about screening NOW!

As we have already, albeit briefly, reported, two “major” papers were published in the New England Journal of Medicine today, and they both were designed to address the appropriateness of mass screening for prostate cancer — among men over the age of 55 years in the USA and over 50 years in Europe respectively.

We wish to state two things immediately:

  • These papers have only (perhaps) resolved one of the many issues that have driven the screening controversy for the past 20 years.
  • What you have or will read in or hear from the mass media almost certainly will be (or already has been) a vast over-simplification of the complexities inherent in these two papers. … READ MORE …

The weekend news reports: February 21, 2009

There are six reports in the news for the weekend, addressing such topics as:

  • DRE for prostate cancer at the time of colonoscopy
  • Development of a 3D transrectal ultrasound-guided biopsy system
  • False-positive biochemical failures after external beam radiotherapy
  • Activity of inactivated Sendai virus particles on HRPC in vitro
  • Male pattern baldness, serum androgen levels, and prostate disorders
  • Psychosocial effects and implications of gynecomastia … READ MORE …

The Friday prostate cancer news reports: January 30, 2009

Today’s news reports are focused on issued around epidemiology, prevention, diagnosis, treatment decisions, and the role of humor in prostate cancer support group interactions. … READ MORE …

Thursday’s prostate cancer news: November 13, 2008

Today’s reports include items on:

  • Perceptions of pain and discomfort in men undergoing DRE
  • 10-year survival data of men with pT3 disease treated initially with a radical prostatectomy
  • Orchiectomy, medical castration, and acceptable social costs
  • Hemi-body radiation to treat pain in men with multiple bone metastases … READ MORE …

Prostate cancer news update: Saturday, August 23

Todays’ reports contain some interesting data, although it is not entirely clear how they should best be applied in the diagnosis and potential management of patients at risk:

  • A study of patient preferences and decision making about how to be treated
  • Why some Brazilian men reject digital rectal examination (fewer that you might expect)
  • The natural history of high-grade prostatic intraepithelial neoplasia (HGPIN)
  • The potential of ferumoxtran-10 (Combidex) in diagnosis of lymph node metastases … READ MORE …